Developing China's biotech industry is a strategic objective for the government, enabled by recent regulatory reforms, greater R&D spend in key segments, and tax incentives in key locations to ...
Hong Kong's tax landscape is characterized by a generally low-tax environment with specific incentives tailored to different sectors. While the region does not provide extensive tax incentives for all ...